A Role for SPARC in the Moderation of Human Insulin Secretion

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Harries, Lorna W ^a   McCulloch, Laura J ^a   Holley, Janet E ^a   Rawling, Thomas J ^a   Welters, Hannah J ^a   Kos, Katarina ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; OSTEONECTIN;

ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RELEASE; LIVER; MALE; MUSCLE; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; SPARC GENE;

ADIPOSE TISSUE; ADULT; CELLS, CULTURED; DIABETES MELLITUS; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIVER; MALE; MIDDLE AGED; MUSCLES; OSTEONECTIN;

EID: 84879526726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068253     Document Type: Article

References (43)

1. Brekken RA, Sage EH, (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix biology: journal of the International Society for Matrix Biology 19: 816-827.
2. Bradshaw AD, (2012) Diverse biological functions of the SPARC family of proteins. The international journal of biochemistry & cell biology 44: 480-488.
3. Delany AM, McMahon DJ, Powell JS, Greenberg DA, Kurland ES, (2008) Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 19: 969-978.
4. Nakamura S, Kamihagi K, Satakeda H, Katayama M, Pan H, et al. (1996) Enhancement of SPARC (osteonectin) synthesis in arthritic cartilage. Increased levels in synovial fluids from patients with rheumatoid arthritis and regulation by growth factors and cytokines in chondrocyte cultures. Arthritis and rheumatism 39: 539-551.
5. Nanba Y, Nishida K, Yoshikawa T, Sato T, Inoue H, et al. (1997) Expression of osteonectin in articular cartilage of osteoarthritic knees. Acta medica Okayama 51: 239-243.
6. Llera AS, Girotti MR, Benedetti LG, Podhajcer OL, (2010) Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer? Cytokine & growth factor reviews 21: 67-76.
7. Frangogiannis NG, (2012) Matricellular proteins in cardiac adaptation and disease. Physiological reviews 92: 635-688.
8. Takahashi M, Nagaretani H, Funahashi T, Nishizawa H, Maeda N, et al. (2001) The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. Obes Res 9: 388-393.
9. Kos K, Wong S, Tan B, Gummesson A, Jernas M, et al. (2009) Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes 58: 1780-1788.
10. Kos K, Wilding JP, (2010) SPARC: a key player in the pathologies associated with obesity and diabetes. Nature reviews Endocrinology 6: 225-235.
11. Wu D, Li L, Yang M, Liu H, Yang GY, (2011) Elevated Plasma Levels of SPARC in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. European journal of endocrinology/European Federation of Endocrine Societies 4: 597-601.
12. Chavey C, Boucher J, Monthouel-Kartmann MN, Sage EH, Castan-Laurell I, et al. (2006) Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia. Obesity 14: 1890-1897.
13. Nie J, Sage EH, (2009) SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. The Journal of biological chemistry 284: 1279-1290.
14. Bornstein P, Sage EH, (2002) Matricellular proteins: extracellular modulators of cell function. Current opinion in cell biology 14: 608-616.
15. Brekken R, Sage H, (2000) SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biology 19: 569-580.
16. Danforth E Jr, (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nature genetics 26: 13.
17. Kotani K, Yamada T, Taniguchi N, (2011) The association between circulating secreted protein acidic and rich in cysteine (SPARC) and glycosylated haemoglobin (HbA(1c)) during lifestyle-modified weight reduction intervention in obese male subjects. The Journal of international medical research 39: 528-532.
18. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
19. Tremble PM, Lane TF, Sage EH, Werb Z, (1993) SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. The Journal of cell biology 121: 1433-1444.
20. Aye T, Toschi E, Sharma A, Sgroi D, Bonner-Weir S, (2010) Identification of markers for newly formed beta-cells in the perinatal period: a time of recognized beta-cell immaturity. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society 58: 369-376.
21. Perez SE, Cano DA, Dao-Pick T, Rougier JP, Werb Z, et al. (2005) Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo. Diabetes 54: 694-701.
22. Fenouille N, Puissant A, Tichet M, Zimniak G, Abbe P, et al. (2011) SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene 30: 4887-4900.
23. Weaver MS, Workman G, Sage EH, (2008) The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase. The Journal of biological chemistry 283: 22826-22837.
24. Hanley SC, Austin E, Assouline-Thomas B, Kapeluto J, Blaichman J, et al. (2010) {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 151: 1462-1472.
25. Szabat M, Kalynyak TB, Lim GE, Chu KY, Yang YH, et al. (2011) Musashi expression in beta-cells coordinates insulin expression, apoptosis and proliferation in response to endoplasmic reticulum stress in diabetes. Cell death & disease 2: e232.
26. Ihm SH, Matsumoto I, Sawada T, Nakano M, Zhang HJ, et al. (2006) Effect of donor age on function of isolated human islets. Diabetes 55: 1361-1368.
27. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
28. Clark A, Jones LC, de Koning E, Hansen BC, Matthews DR, (2001) Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function? Diabetes 50Suppl 1: S169-171.
29. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
30. Framson PE, Sage EH, (2004) SPARC and tumor growth: where the seed meets the soil? Journal of cellular biochemistry 92: 679-690.
31. Henquin JC, (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49: 1751-1760.
32. Portela M, Casas-Tinto S, Rhiner C, Lopez-Gay JM, Dominguez O, et al. (2010) Drosophila SPARC is a self-protective signal expressed by loser cells during cell competition. Developmental cell 19: 562-573.
33. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, et al. (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54Suppl 2: S97-107.
34. Chang-Chen KJ, Mullur R, Bernal-Mizrachi E, (2008) Beta-cell failure as a complication of diabetes. Reviews in endocrine & metabolic disorders 9: 329-343.
35. Fenouille N, Robert G, Tichet M, Puissant A, Dufies M, et al. (2011) The p53/p21Cip1/Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. Pigment cell & melanoma research 24: 219-232.
36. Bhoopathi P, Chetty C, Dontula R, Gujrati M, Dinh DH, et al. (2011) SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway. Cancer research 71: 4908-4919.
37. Landsman L, Parent A, Hebrok M, (2011) Elevated Hedgehog/Gli signaling causes beta-cell dedifferentiation in mice. Proceedings of the National Academy of Sciences of the United States of America 108: 17010-17015.
38. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
39. Rosengren AH, Braun M, Mahdi T, Andersson SA, Travers ME, et al. (2012) Reduced Insulin Exocytosis in Human Pancreatic beta-cells With Gene Variants Linked to Type 2 Diabetes. Diabetes 61: 1726-1733.
40. da Silva Xavier G, Loder MK, McDonald A, Tarasov AI, Carzaniga R, et al. (2009) TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 58: 894-905.
41. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, et al. (2009) Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Molecular and cellular biology 29: 1575-1591.
42. Nie J, Bradshaw AD, Delany AM, Sage EH, (2011) Inactivation of SPARC enhances high-fat diet-induced obesity in mice. Connective tissue research 52: 99-108.
43. Song H, Guan Y, Zhang L, Li K, Dong C, (2010) SPARC interacts with AMPK and regulates GLUT4 expression. Biochemical and biophysical research communications 396: 961-966.